Expression of matrix metalloproteinase-9 in human platelets: Regulation of platelet activation in in vitro and in vivo studies

British Journal of Pharmacology

Volumn 143, Issue 1, 2004, Pages 193-201

  Sheu, Joera R ^a   Fong, Tsorng H ^a   Liu, Cheng M ^a   Shen, Ming Y ^a   Chen, Ta L ^a   Chang, Yi ^a   Lu, Meng S ^a   Hsiao, George ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Arterial thrombosis; Immunogold; Matrix metalloproteinase 9; Platelet aggregation; Protein kinase C

Indexed keywords

CALCIUM; COLLAGEN; CYCLIC GMP; FLUORESCEIN SODIUM; GELATINASE B; INOSITOL PHOSPHATE; NITRIC OXIDE; PHORBOL DIBUTYRATE; PHOSPHATIDYLINOSITIDE; PHOSPHOLIPASE C; PROTEIN KINASE C; PROTEIN P47; THROMBOXANE A2; THROMBOXANE B2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM MOBILIZATION; CAPILLARY ZONE ELECTROPHORESIS; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; IMMUNOGOLD ELECTRON MICROSCOPY; IN VITRO STUDY; IN VIVO STUDY; MESENTERIC VEIN; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOGENESIS; VEIN THROMBOSIS;

ANIMALS; BLOOD PLATELETS; CAPILLARIES; CELL MEMBRANE; CYCLIC AMP; CYCLIC GMP; ELECTROPHORESIS, CAPILLARY; FLUORESCEIN; FLUORESCENT DYES; FURA-2; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 9; MICE; NITRATES; PHOSPHOLIPIDS; PLATELET ACTIVATION; PLATELET AGGREGATION; PROTEIN KINASE C; SPLANCHNIC CIRCULATION; THROMBOXANE B2;

EID: 4644299706     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705917     Document Type: Article

References (26)

1. BERRIDGE, M.J. (1983). Rapid accumulation of inositol trisphosphate reveals that agonists hydrolyse polyphosphoinositides instead of phosphatidylinositol. Biochem. J., 212, 249-258.
2. BIRKEDAL-HANSEN, H. (1995). Proteolytic remodeling of extracellular matrix. Curr. Opin. Cell Biol., 7, 728-735.
3. BORN, G.V.R. & CROSS, M.J. (1963). The aggregation of blood platelets. J. Physiol., 168, 178-195.
4. BROEKMAN, M.J., WARD, J.W. & MARCUS, A.J. (1980). Phospholipid metabolism in stimulated human platelets. Changes in phosphatidyl inositol, phosphatic acid and lysophospholipids. J. Clin. Invest., 66, 275-278.
5. CHARO, I.F., FEINMAN, R.D. & DETWILER, T.C. (1976). Inhibition of platelet secretion by an antagonist of intracellular calcium. Biochem. Biophys. Res. Commun., 72, 1462-1467.
6. DOLLERY, C.M., McEWAN, J.R. & HENNEY, A.M. (1995). Matrix metalloproteinases and cardiovascular diseases. Circ. Res., 77, 863-868.
7. FERNANDEZ-PATRON, C., MARTINEZ-CUESTA, M.A., SALAS, E., SAWICKI, G., WOZNIAK, M., RADOMSKI, M.W. & DAVIDGE, S.T. (1999). Differential regulation of platelet aggregation by matrix metalloproteinases-9 and -2. Thromb. Haemost., 82, 1730-1735.
8. GRABAREK, J., RAYCHOWDHURY, M., RAVID, K., KENT, K.C., NEWMAN, P.J. & WARE, J.A. (1992). Identification and functional characterization of protein kinase C isozymes in platelets and HEL cells. J. Biol. Chem.. 267, 10011-10017.
9. +2 indicator with greatly improved fluorescence properties. J. Biol. Chem., 260, 3440-3450.
10. 2 production. Biochem. Pharmacol., 31, 1158-1160.
11. KARNIGUIAN, A., LEGRAND, Y.J. & CAEN, J.P. (1982). Prostaglandins: specific inhibition of platelet adhesion to collagen and relationship with cyclic AMP level. Prostaglandins, 23, 437-457.
12. KIRK, C.J., CREBA, J.A., DOENES, C.P. & MICHELL, R.H. (1981). Hormone-stimulated metabolism of inositol lipids and its relationship to hepatic receptor function. Biochem. Soc. Trans., 9, 377-379.
13. +2, phospholipid-dependent protein kinase associated with plasma membrane. Nature, 301, 621-623.
14. LIJNEN, H.R. (2001). Plasmin and matrix metalloproteinases in vascular remodeling. Thromb. Haemost., 86, 324-333.
15. MARCY, A.I., EIBERGER, L.L., HARRISON, R., CHAN, H.K., HUTCHINSON, N.I., HAGMANN, W.K., CAMERON, P.M., BOULTON, D.A. & HERMES, J.D. (1991). Human fibroblast stromelysin catalytic domain: expression, purification, and characterization of a C-terminally truncated form. Biochemistry, 30, 6476-6483.
16. McDONALD, L.J. & MURAD, F. (1996). Nitric oxide and cyclic GMP signaling. Proc. Soc. Exp. Biol. Med., 211, 1-6.
17. McKEAN, M.L., SMITH, J.B. & SILVER, W.J. (1981). Formation of lysophosphatidylcholine in human platelets in response to thrombin. J. Biol. Chem., 256, 1522-1524.
18. MUROHARA, T., PARKINSON, S.J., WAQLDMAN, S.A. & LEFER, A.M. (1995). Inhibition of nitric oxide biosynthesis promotes P-selectin expression in platelets. Role of protein kinase C. Arterioscler. Thromb. Vasc. Biol., 15, 2068-2075.
19. NAKAMURA, T., EBIHARA, I., SHIMADA, N. & KOIDE, H. (1998). Effect of cigarette smoking on plasma metalloproteinases-9 concentration. Clin. Chim. Acta, 276, 173-177.
20. RAY, J.M. & STETLER-STEVENSON, W.G. (1994). The role of matrix metalloproteinases and their inhibitors in tumor invasion, metastasis and angiogenesis. Eur. Respir. J., 7, 2062-2072.
21. SAWICKI, G., SALAS, E., MURAT, J., MISZTA-LANE, H. & RADOMSKI, M.W. (1997). Release of gelatinase A during platelet activation mediates aggregation. Nature, 386, 616-618.
22. SHEU, J.R., CHAO, S.H., YEN, M.H. & HUANG, T.F. (1994). In vivo antithrombotic effect of triflavin, an Arg-Gly-Asp containing peptide on platelet plug formation in mesenteric microvessels of mice. Thromb. Haemost., 72, 617-621.
23. SHEU, J.R., HUNG, W.C., SU, C.H., LIN, C.H., LEE, L.W., LEE, Y.M. & YEN, M.H. (1999a). The antiplatelet activity of Escherichia coli lipopolysaccharide, is mediated through nitric oxide/cyclic GMP pathway. Eur. J. Haematol., 62, 317-326.
24. SHEU, J.R., HUNG, W.C., WU, C.H., MA, M.C., KAN, Y.C., LIN, C.H., LIN, M.S., LUK, H.N. & YEN, M.K. (1999b). Reduction in lipopolysaccharide-induced thrombocytopenia by triflavin in a rat model of septicemia. Circulation, 99, 3056-3062.
25. SHEU, J.R., LEE, C.R., LIN, C.C., KAN, Y.C., LIN, C.H., HUNG, W.C., LEE, Y.M. & YEN, M.H. (1999c). The antiplatelet activity of PMC, a potent α-tocopherol analogue, is mediated through inhibition of cyclooxygenase. Br. J. Pharmacol., 127, 1206-1212.
26. SIESS, W. & LAPETINA, E.G. (1989). Platelet aggregation induced by alpha 2-adrenoceptor and protein kinase C activation. A novel synergism. Biochem. J., 263, 377-385.